Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Effect of Purinoyl Human Serum Albumin on Transplanted Ehrlich Ascites Tumour in Mice

Abstract

PURINOYL human serum albumin elicits in rabbits purine-specific antibodies which also cross-react with single-stranded deoxyribonucleic acid1. It seemed of interest to investigate the effect of this antigen on tumour-bearing animals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Butler, V. P., Beiser, S. M., Erlanger, B. F., Tanenbaum, S. W., Cohen, S., and Bendich, A., Proc. U.S. Nat. Acad. Sci., 48, 1597 (1962).

    Article  ADS  CAS  Google Scholar 

  2. Ryser, H., Aub, J. C., and Caulfield, J. B., J. Cell. Biol., 15, 437 (1962).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SINAI, Y., LACHMAN, C. & COHEN, S. Effect of Purinoyl Human Serum Albumin on Transplanted Ehrlich Ascites Tumour in Mice. Nature 205, 192–193 (1965). https://doi.org/10.1038/205192a0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/205192a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing